Document is current
Any future updates will be listed below
-
Authors
Reis, Erik Vinicius de Sousa
Ferreira, Linziane Lopes
Clarindo, Felipe Alves
Marques-Ferreira, Geovane
de Oliveira, Leonardo Camilo
Moraes, Thaís de Fátima Silva
de Carvalho, Luciana Debortoli
da Fonseca, Flávio Guimarães
Sabino, Adriano de Paula
Eapen, Mathew Suji
Teixeira, Mauro Martins
Valle, Sarah J.
Morris, David L.
Coelho-dos-Reis, Jordana Grazziela Alves
- License Information
-
More Information
Article History
Received: 1 October 2024
Accepted: 26 February 2025
First Online: 7 April 2025
Declarations
:
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. DLM, SJV and MSE are employed by MucPharm. All the remaining authors declare no conflict of interest.
: Research was approved by Institutional Research Board Committee. This research had approval from the Brazilian Institutional Ethics Committee (Approval number: 45919121.6.0000.5526). There was written consent from the next of kin on behalf of the patients for participation in the research. This study followed the principles of the Helsinki Declaration and resolution #466/2012 of the Brazilian Ministry of Health for research involving human subjects.
: Informed consent was obtained by next of kin of all participants enrolled in the study.
